Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 3, 2020

EUSA Pharma gets FDA nod for phase 3 Covid-19 trial for Siltuximab

EUSA Pharma said that the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled Phase 3 clinical trial protocol to evaluate the safety and efficacy of intravenous siltuximab plus standard of care in hospitalized patients with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS).

EUSA Pharma gets FDA nod for phase 3 Covid-19 trial for Siltuximab